Billionaire Profile
Banwari Lal Bawri
Global Rank
#2079

Image: Public domain | via Wikimedia Commons

Banwari Lal Bawri

CEO, Macleods Pharmaceuticals
IN
Real-Time Net Worth
$1.9B
As of December 2025
Age
72
Source
Pharmaceuticals
Industry
healthcare
Citizenship
IN

Biography

Banwari Lal Bawri, aged 72, is a prominent Indian billionaire. He is the Joint Managing Director of Macleods Pharmaceuticals, a leading pharmaceutical company in India, and is a key figure in the Indian healthcare industry. Bawri's primary source of wealth stems from his involvement in the pharmaceutical sector, where he and his brothers established Macleods Pharmaceuticals in 1986. Macleods produces a variety of generic medications, which contributed significantly to his $1.9 billion net worth. Bawri's career highlights his commitment to providing affordable healthcare solutions and expanding his company's global presence, making him one of the richest individuals in India.

Wealth Over Time

In-Depth Profile

Early Life

Banwari Lal Bawri, along with his brothers Girdhari Lal Bawri and Rajendra Agarwal, comes from a family that owned a pharmacy in Jaipur. This early exposure to the pharmaceutical world laid the foundation for their future endeavors. The family's background instilled a deep understanding of the healthcare industry and a passion for making medicines accessible.

Rise to Success

In 1986, Banwari Lal Bawri, along with his brothers, founded Macleods Pharmaceuticals with the aim of manufacturing anti-TB medicines. Over the years, the company grew from a modest start-up into a global pharmaceutical company, with a presence in more than 170 countries. Macleods Pharmaceuticals is now recognized for its extensive portfolio of generic medications and a robust presence across numerous international markets, making it one of the top pharmaceutical companies in India.

Key Business Strategies

Key to Macleods' success was its focus on producing high-quality generic medicines for a range of diseases. The company's strategic investments in research and development, along with a strong distribution network, have enabled it to compete effectively in the global market. Macleods Pharmaceuticals has focused on treatments for conditions including asthma, osteoporosis, and diabetes, contributing significantly to Bawri's wealth and the company's reputation.

Philanthropy

While specific amounts are unavailable, the Bawri brothers have been recognized for their philanthropic endeavors and contributions to society. The triumvirate of Girdhari Lal Bawri, Rajendra Agarwal, and Banwari Lal Bawri have been honored with numerous prestigious awards and accolades for their exemplary contributions to business and society.

Career Milestones

1986

Co-founded Macleods Pharmaceuticals

Established Macleods Pharmaceuticals with his brothers to manufacture anti-TB medicines.

2000

Established first R&D center

Macleods established its first Research & Development center in Mumbai

Philanthropy & Social Impact

General

Various initiatives

Undisclosed

The Bawri brothers have been recognized for their philanthropic endeavors and contributions to society.